Download PDF
Semin Neurol 2014; 34(03): 306-311
DOI: 10.1055/s-0034-1386768
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Genetics and Pathophysiology of Primary Dystonia with Special Emphasis on DYT1 and DYT5

Masaya Segawa
1   Segawa Neurological Clinic for Children, Tokyo, Japan
,
Yoshiko Nomura
1   Segawa Neurological Clinic for Children, Tokyo, Japan
› Author Affiliations
Further Information

Publication History

Publication Date:
05 September 2014 (online)

    Permissions and Reprints

Abstract

DYT1 and DYT5 are early-onset dominant inherited dystonias. DYT1 is caused by mutations of the TOR1A gene, located on 9q34, which causes dysfunction of the D1 direct pathway or the indirect pathway. Dysfunction of the former causes postural-type and segmental dystonia; the latter causes action-type dystonia. In families with action-type dystonia, there are cases with focal and segmental dystonia. Ages of onset of postural-type dystonia are around 6 years, and 8 to 10 years in cases of action-type dystonia. Focal and segmental dystonia develops in the teens. Mental and psychological functions are preserved. DYT5 is caused by heterozygous mutations of the GCH1 gene, located on 14q22.1-q22.2. Again, mental and psychological functions are preserved. Clinically, there are two types: postural and action. Postural-type dystonia occurs around 6 years of age, with postural dystonia of one leg, and all extremities and trunk muscles are involved by the late teens. Action-type dystonia shows dystonic movements from around 8 to 10 years of age. In both types, all symptoms show diurnal fluctuations that diminish with age and are no longer apparent in the late teens. L-dopa produces dramatic effects, which continue throughout the course of the illness. In both postural and action types, each family or sporadic case has a particular mutation. It remains unclear why specific mutations cause certain age- and gender-specific symptoms.

Keywords

DYT1 - DYT5 - Dopa-Responsive dystonia - Segawa disease - postural-type dystonia - action-type dystonia
 

  • References

  • 1 Ichinose H, Ohye T, Takahashi E , et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994; 8 (3) 236-242
    CrossrefPubMedGoogle Scholar
  • 2 Ozelius LJ, Hewett JW, Page CE , et al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 1997; 17 (1) 40-48
    CrossrefPubMedGoogle Scholar
  • 3 Klein C. Genetics in dystonia. Parkinsonism Relat Disord 2014; 20 (Suppl. 01) S137-S142
    CrossrefPubMedGoogle Scholar
  • 4 McGeer EG, McGeer PL. Some characteristics of brain tyrosine hydroxylase. In: Mandel J, , ed. New Concepts in Neurotransmitter Regulation. New York, NY: Plenum; 1973: 53-68
    CrossrefGoogle Scholar
  • 5 Morgante F, Klein C. Dystonia. Continuum (Minneap Minn) 2013; 19 (5 Movement Disorders): 1225-1241
    PubMedGoogle Scholar
  • 6 Kramer PL, de Leon D, Ozelius L , et al. Dystonia gene in Ashkenazi Jewish population is located on chromosome 9q32-34. Ann Neurol 1990; 27 (2) 114-120
    CrossrefPubMedGoogle Scholar
  • 7 Nomura Y, Ikeuchi T, Tsuji S, Segawa M. Two phenotypes and anticipation observed in Japanese cases with early onset torsion dystonia (DYT1) - pathophysiological consideration. Brain Dev 2000; 22 (Suppl. 01) S92-S101
    CrossrefPubMedGoogle Scholar
  • 8 Neuwald AF, Aravind L, Spouge JL, Koonin EV. AAA+: A class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res 1999; 9 (1) 27-43
    PubMedGoogle Scholar
  • 9 Lupas A, Flanagan JM, Tamura T, Baumeister W. Self-compartmentalizing proteases. Trends Biochem Sci 1997; 22 (10) 399-404
    CrossrefPubMedGoogle Scholar
  • 10 Thompson ML, Chen P, Yan X , et al. TorsinA rescues ER-associated stress and locomotive defects in C. elegans models of ALS. Dis Model Mech 2014; 7 (2) 233-243
    CrossrefPubMedGoogle Scholar
  • 11 Rostasy K, Augood SJ, Hewett JW , et al. TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion. Neurobiol Dis 2003; 12 (1) 11-24
    CrossrefPubMedGoogle Scholar
  • 12 Augood SJ, Keller-McGandy CE, Siriani A , et al. Distribution and ultrastructural localization of torsinA immunoreactivity in the human brain. Brain Res 2003; 986 (1–2) 12-21
    CrossrefPubMedGoogle Scholar
  • 13 Shashidharan P, Kramer BC, Walker RH, Olanow CW, Brin MF. Immunohistochemical localization and distribution of torsinA in normal human and rat brain. Brain Res 2000; 853 (2) 197-206
    CrossrefPubMedGoogle Scholar
  • 14 Naismith TV, Heuser JE, Breakefield XO, Hanson PI. TorsinA in the nuclear envelope. Proc Natl Acad Sci U S A 2004; 101 (20) 7612-7617
    CrossrefPubMedGoogle Scholar
  • 15 Goodchild RE, Dauer WT. Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation. Proc Natl Acad Sci U S A 2004; 101 (3) 847-852
    CrossrefPubMedGoogle Scholar
  • 16 Hewett JW, Zeng J, Niland BP, Bragg DC, Breakefield XO. Dystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics. Neurobiol Dis 2006; 22 (1) 98-111
    CrossrefPubMedGoogle Scholar
  • 17 O'Farrell CA, Martin KL, Hutton M, Delatycki MB, Cookson MR, Lockhart PJ. Mutant torsinA interacts with tyrosine hydroxylase in cultured cells. Neuroscience 2009; 164 (3) 1127-1137
    CrossrefPubMedGoogle Scholar
  • 18 Kamm C, Boston H, Hewett J , et al. The early onset dystonia protein torsinA interacts with kinesin light chain 1. J Biol Chem 2004; 279 (19) 19882-19892
    CrossrefPubMedGoogle Scholar
  • 19 Hewett JW, Tannous B, Niland BP , et al. Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells. Proc Natl Acad Sci U S A 2007; 104 (17) 7271-7276
    CrossrefPubMedGoogle Scholar
  • 20 Nery FC, Zeng J, Niland BP , et al. TorsinA binds the KASH domain of nesprins and participates in linkage between nuclear envelope and cytoskeleton. J Cell Sci 2008; 121 (Pt 20) 3476-3486
    CrossrefPubMedGoogle Scholar
  • 21 Naismith TV, Dalal S, Hanson PI. Interaction of torsinA with its major binding partners is impaired by the dystonia-associated DeltaGAG deletion. J Biol Chem 2009; 284 (41) 27866-27874
    CrossrefPubMedGoogle Scholar
  • 22 Torres GE, Sweeney AL, Beaulieu JM, Shashidharan P, Caron MG. Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant. Proc Natl Acad Sci U S A 2004; 101 (44) 15650-15655
    CrossrefPubMedGoogle Scholar
  • 23 Giles LM, Chen J, Li L, Chin LS. Dystonia-associated mutations cause premature degradation of torsinA protein and cell-type-specific mislocalization to the nuclear envelope. Hum Mol Genet 2008; 17 (17) 2712-2722
    CrossrefPubMedGoogle Scholar
  • 24 Giles LM, Li L, Chin LS. TorsinA protein degradation and autophagy in DYT1 dystonia. Autophagy 2009; 5 (1) 82-84
    CrossrefPubMedGoogle Scholar
  • 25 Goodchild RE, Kim CE, Dauer WT. Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 2005; 48 (6) 923-932
    CrossrefPubMedGoogle Scholar
  • 26 Risch NJ, Bressman SB, Senthil G, Ozelius LJ. Intragenic Cis and Trans modification of genetic susceptibility in DYT1 torsion dystonia. Am J Hum Genet 2007; 80 (6) 1188-1193
    CrossrefPubMedGoogle Scholar
  • 27 Segawa M, Nomura Y, Nishiyama N. Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol 2003; 54 (Suppl. 06) S32-S45
    PubMedGoogle Scholar
  • 28 Segawa M. Hereditary progressive dystonia with marked diurnal fluctuation. Brain Dev 2000; 22 (Suppl. 01) S65-S80
    PubMedGoogle Scholar
  • 29 Lee WW, Jeon BS. Clinical spectrum of dopa-responsive dystonia and related disorders. Curr Neurol Neurosci Rep 2014; 14 (7) 461
    CrossrefPubMedGoogle Scholar
  • 30 Wu-Chou YH, Yeh TH, Wang CY , et al. High frequency of multiexonic deletion of the GCH1 gene in a Taiwanese cohort of dopa-response dystonia. Am J Med Genet B Neuropsychiatr Genet 2010; 153B (4) 903-908
    PubMedGoogle Scholar
  • 31 Bandmann O, Valente EM, Holmans P , et al. Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol 1998; 44 (4) 649-656
    CrossrefPubMedGoogle Scholar
  • 32 Furukawa Y, Nygaard TG, Gütlich M , et al. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Neurology 1999; 53 (5) 1032-1041
    CrossrefPubMedGoogle Scholar
  • 33 Furukawa Y, Kapatos G, Haycock JW , et al. Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia. Ann Neurol 2002; 51 (5) 637-641
    CrossrefPubMedGoogle Scholar